Efficacy and Safety of Durvalumab in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis

NCT04356222 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Leptomeningeal Metastasis
Durvalumab

Interventions

DRUG: Durvalumab
DRUG: methotrexate

Sponsor

Hui Bu